Deutsche Bank
CMMB

Deutsche Bank’s Chemomab Therapeutics CMMB Stock Holding History

Deutsche Bank’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5
Closed – – 4997
2019
Q3 		$0 Buy
+5
New +$972 ﹤0.01% 4931

Other funds holding CMMB

MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Deutsche Bank's CMMB Position: Q4 2019 in Review

Deutsche Bank sold out of Chemomab Therapeutics (CMMB) in Q4 2019, closing a stake of 5 shares.

Deutsche Bank first reported a position in CMMB in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 5 funds tracked by Wall St. Rank hold CMMB as of Q4 2019.

  • Deutsche Bank reported no remaining Chemomab Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Deutsche Bank sold 5 Chemomab Therapeutics shares in Q4 2019.
  • Deutsche Bank first reported a position in Chemomab Therapeutics in Q3 2019 and held it in 1 quarter.
  • Deutsche Bank's Chemomab Therapeutics position peaked at $0 in Q3 2019.
  • 5 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q4 2019.

Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.